RADIATION EXPOSURE FROM DIAGNOSTIC PROCEDURES IN ALLOGENEIC STEM CELL TRANSPLANTATION DOES NOT SIGNIFICANTLY IMPACT OVERALL SURVIVAL OR NON-RELAPSE MORTALITY

被引:0
|
作者
Battiwalla, M. [1 ]
Fakhrejahani, F. [1 ]
Klotz, J. [1 ]
Pophali, P. [1 ]
Draper, D. [1 ]
Haggerty, J. [1 ]
McIver, Z. [1 ]
Chawla, K. [1 ]
Ito, S. [1 ]
Barrett, J. [1 ]
机构
[1] NHLBI, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/j.bbmt.2011.12.361
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
370
引用
收藏
页码:S341 / S341
页数:1
相关论文
共 50 条
  • [1] Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients
    Solano, Carlos
    Gimenez, Estela
    Luis Pinana, Jose
    Albert, Eliseo
    Vinuesa, Victor
    Carlos Hernandez-Boluda, Juan
    Amat, Paula
    Navarro, David
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (04)
  • [2] Optimising patient selection for allogeneic stem cell transplantation: prediction of non-relapse mortality and survival
    Pavlu, J.
    Rezvani, K.
    Kishore, B.
    Chakrabartty, J.
    Shah, R.
    Auner, H. W.
    Milojkovic, D.
    Marin, D.
    Rahemtulla, A.
    MacDonald, D. H.
    Kanfer, E. J.
    Dazzi, F.
    Goldman, J. M.
    Apperley, J. F.
    Szydlo, R. M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S27 - S28
  • [3] SEROLOGICAL EVIDENCE OF HEPATITIS C IS ASSOCIATED WITH WORSE NON-RELAPSE MORTALITY AND OVERALL SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Ramos, C. A.
    Saliba, R. M.
    Khorshid, O.
    de Padua, L.
    Giralt, S.
    Andersson, B. S.
    Ueno, N. T.
    Shpall, E. J.
    Hosing, C.
    Qureshi, S. R.
    Champlin, R. E.
    de Lima, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 103 - 104
  • [4] The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation
    Joshua A. Fein
    Avichai Shimoni
    Myriam Labopin
    Noga Shem-Tov
    Ronit Yerushalmi
    Hila Magen
    Nadav Furie
    Eli Kopel
    Ivetta Danylesko
    Arnon Nagler
    Roni Shouval
    Leukemia, 2018, 32 : 1787 - 1794
  • [5] The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation
    Fein, Joshua A.
    Shimoni, Avichai
    Labopin, Myriam
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Magen, Hila
    Furie, Nadav
    Kopel, Eli
    Danylesko, Ivetta
    Nagler, Arnon
    Shouval, Roni
    LEUKEMIA, 2018, 32 (08) : 1787 - 1794
  • [6] IMPACT OF SMOKING ON THE NON-RELAPSE MORTALITY, THE OVERALL SURVIVAL, AND THE INCIDENCE OF SECOND CANCERS AFTER REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    Spina, F.
    De Philippis, C.
    Farina, L.
    Montefusco, V.
    Dodero, A.
    Corradini, P.
    HAEMATOLOGICA, 2014, 99 : 164 - 165
  • [7] Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
    Galvin, John P.
    Ehrlich, Katherine
    Baveja, Swati
    Scheide, Thomas
    Valukas, Catherine
    Penedo, Frank
    Miller, Greg
    Mehta, Jayesh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S175 - S176
  • [8] It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)
    Luft, Thomas
    Benner, Axel
    Jodele, Sonata
    Dandoy, Christopher E.
    Storb, Rainer F.
    Gooley, Ted A.
    Sandmaier, Brenda M.
    Radujkovic, Aleksandar
    Ho, Anthony D.
    Dreger, Peter
    Penack, Olaf
    BLOOD, 2016, 128 (22)
  • [9] Treatment of myelodysplastic syndromes with allogeneic hematopoietic stem cell transplantation (HSCT)-impact of non-relapse mortality on outcomes
    Ativitavas, T
    Saliba, R
    Sergio, G
    Ghosh, S
    Champlin, R
    de Lima, M
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 28 - 29
  • [10] Late non-relapse mortality after allogeneic hematopoietic cell transplantation: the impact of bronchiolitis obliterans
    Ozdemir Kumbasar, O
    Arat, M
    Beksac, M
    Ilhan, O
    Alper, D
    Koc, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S215 - S215